NCT02626221 - A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan) | Biotech Hunter

Enrollment

497

Participants

Timeline

Start Date

December 24, 2014

Primary Completion Date

March 21, 2018

Study Completion Date

March 21, 2018

Conditions

Chronic Urticaria

Interventions

OTHER

Non Interventional Study

Trial Locations (31)

11

Novartis Investigative Site, Jesus Maria

31

Novartis Investigative Site, San Martín de Porres

2000

Novartis Investigative Site, Rosario

4400

Novartis Investigative Site, Salta

21102

Novartis Investigative Site, San Pedro Sula

C1062ABK

Novartis Investigative Site, CABA

C1114AAJ

Novartis Investigative Site, Ciudad Autonoma de Bs As

C1425BEA

Novartis Investigative Site, Ciudad Autonoma de Bs As

Unknown

Novartis Investigative Site, Lobos

Novartis Investigative Site, Medellín

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Medellín

Novartis Investigative Site, San José

Novartis Investigative Site, San Rafael Escazu

Novartis Investigative Site, Santiago de los Caballeros

Novartis Investigative Site, Santo Domingo

Novartis Investigative Site, San Pedro Sula

Novartis Investigative Site, Tegucigalpa

Novartis Investigative Site, Panama City

B6500BWQ

Novartis Investigative Site, Buenos Aires

S2000BRH

Novartis Investigative Site, Rosario

C1425DKG

Novartis Investigative Site, Buenos Aires

M5502EZA

Novartis Investigative Site, Mendoza

21941-913

Novartis Investigative Site, Rio de Janeiro

06454-010

Novartis Investigative Site, Alphaville / Barueri

07051-000

Novartis Investigative Site, Guarulhos

09060-650

Novartis Investigative Site, Santo André

05437-000

Novartis Investigative Site, São Paulo

01010

Novartis Investigative Site, Guatemala City